Francis Duhay - 12 Mar 2026 Form 4 Insider Report for enVVeno Medical Corp (NVNO)

Role
Director
Signature
/s/ Francis Duhay
Issuer symbol
NVNO
Transactions as of
12 Mar 2026
Net transactions value
-$1,613
Form type
4
Filing time
13 Mar 2026, 16:05:09 UTC
Previous filing
15 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Duhay Francis Director C/O ENVVENO MEDICAL CORPORATION,, 70 DOPPLER, IRVINE /s/ Francis Duhay 13 Mar 2026 0001760582

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVNO Common Stock Sale $1,613 -140 -5.3% $11.52 2,502 12 Mar 2026 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This transaction was completed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in June 2025.
F2 This transaction was executed in multiple trades during the day at prices ranging from $11.5200 to $11.5450, inclusive. The weighted-average price is reported above. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were completed.